Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001529224-21-000003
Filing Date
2021-01-13
Accepted
2021-01-13 10:19:12
Documents
1
Effectiveness Date
2021-01-13
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 9058
  Complete submission text file 0001529224-21-000003.txt   10227
Mailing Address 100 CAPITOLA DRIVE SUITE 275 DURHAM NC 27713
Business Address 100 CAPITOLA DRIVE SUITE 275 DURHAM NC 27713 (919) 973-6544
GeneCentric Therapeutics, Inc. (Filer) CIK: 0001529224 (see all company filings)

IRS No.: 452540158 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-386126 | Film No.: 21525313